Gene · 4211
Papers2,719
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,719
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ancestry-specific and multi-ancestry genome-wide association studies of restless legs syndrome. | medRxiv | 2026 | 42145650 | PubTator, text mining | PubMed |
| A Novel MEIS1::NCOA2 Fusion Gene in Acute Myeloid Leukemia. | Genes Chromosomes Cancer | 2026 | 42138464 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemias with Alterations of Lysine Methyltransferase 2A (KMT2A): Recent Therapeutic Developments. | Cancers (Basel) | 2026 | 42122138 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals immune microenvironment heterogeneity in BRCA1-mutated and sporadic triple-negative breast cancer. | Transl Oncol | 2026 | 42119173 | PubTator, text mining | PubMed |
| Single-cell multiomic and spatial landscape of the primate pineal gland reveals circadian and melatonin regulatory architecture. | Proc Natl Acad Sci U S A | 2026 | 42085153 | PubTator, text mining | PubMed |
| Down-regulation of circ0001361 induces apoptosis and suppresses the progression of glioma. | PLoS One | 2026 | 41984870 | PubTator, text mining | PubMed |
| Danthron as a novel IL-6R agonist promotes thrombopoiesis via the SRC/RAS/MAPK pathway. | Front Immunol | 2026 | 41972146 | PubTator, text mining | PubMed |
| Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2Ar and NPM1-m AML. | bioRxiv | 2026 | 41959134 | PubTator, text mining | PubMed |
| Nuclear transcriptional condensates as drivers and therapeutic targets in NPM1-mutated AML. | Blood | 2026 | 41949617 | PubTator, text mining | PubMed |
| Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation. | Eur J Haematol | 2026 | 41923577 | PubTator, text mining | PubMed |
| Genetic architecture of sleep in a genome wide association study of device measured sleep traits. | Nat Commun | 2026 | 41922918 | PubTator, text mining | PubMed |
| Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. | J Pers Med | 2026 | 41893037 | PubTator, text mining | PubMed |
| ROS-Mediated Cardiomyocyte Proliferation and Myocardial Regeneration: Mechanisms and Targeted Strategies for Ischemic Heart Disease. | J Cardiovasc Dev Dis | 2026 | 41892695 | PubTator, text mining | PubMed |
| IFN-γ induces hematopoietic stem cell myelopoiesis through Meis1 in tumor. | Stem Cell Res Ther | 2026 | 41877254 | PubTator, text mining | PubMed |
| Meis1-driven suppression of MIF/CD74 signaling promotes M2 macrophage polarization and protects against inflammatory damage in experimental acute lung injury. | Cell Biol Toxicol | 2026 | 41862651 | PubTator, text mining | PubMed |
| Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. | Blood | 2026 | 41849234 | PubTator, text mining | PubMed |
| Ubiquitination of MEIS1 by MDM2 serves as a switch for p53 stabilization and DNA damage response activation. | Cell Death Differ | 2026 | 41826728 | PubTator, text mining | PubMed |
Adolescent Insomnia Disorder - Problematic Internet Use Nexus: A Convergent Developmental Trajectory - Bridging Neuroimaging Biomarkers, Molecular Susceptibility, and Environmental-Neurocognitive Cascades. | Psychol Res Behav Manag | 2026 | 41809717 | PubTator, text mining | PubMed |
| Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. | Oncol Res | 2026 | 41799513 | PubTator, text mining | PubMed |
| TDG orchestrates ATF4-dependent gene transcription during retinoic acid-induced cell fate acquisition. | Nucleic Acids Res | 2026 | 41773019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4211/papers?page=2